» Articles » PMID: 29844933

MiRNAs Reshape Immunity and Inflammatory Responses in Bacterial Infection

Overview
Date 2018 May 31
PMID 29844933
Citations 64
Authors
Affiliations
Soon will be listed here.
Abstract

Pathogenic bacteria cause various infections worldwide, especially in immunocompromised and other susceptible individuals, and are also associated with high infant mortality rates in developing countries. MicroRNAs (miRNAs), small non-coding RNAs with evolutionarily conserved sequences, are expressed in various tissues and cells that play key part in various physiological and pathologic processes. Increasing evidence implies roles for miRNAs in bacterial infectious diseases by modulating inflammatory responses, cell penetration, tissue remodeling, and innate and adaptive immunity. This review highlights some recent intriguing findings, ranging from the correlation between aberrant expression of miRNAs with bacterial infection progression to their profound impact on host immune responses. Harnessing of dysregulated miRNAs in bacterial infection may be an approach to improving the diagnosis, prevention and therapy of infectious diseases.

Citing Articles

Neutrophil-modulated Dicer expression in macrophages influences inflammation resolution.

Wang Z, Li W, Li J, Jin T, Chen H, Liang F Cell Mol Life Sci. 2025; 82(1):114.

PMID: 40074991 PMC: 11904050. DOI: 10.1007/s00018-025-05644-6.


MicroRNAs in HIV infection: dual regulators of viral replication and host immunity.

Mansour R, El-Sayyad G, Rizk N, Mageed S, Basiouny M, El-Sayed S Naunyn Schmiedebergs Arch Pharmacol. 2025; .

PMID: 40029387 DOI: 10.1007/s00210-025-03893-7.


Non-coding RNA Networks in Infection.

Janga H, Schmerer N, Aznaourova M, Schulte L Methods Mol Biol. 2024; 2883:53-77.

PMID: 39702704 DOI: 10.1007/978-1-0716-4290-0_3.


Unlocking the potential of miRNAs in detecting pulmonary tuberculosis: prospects and pitfalls.

Arya R, Kumar S, Vinetz J, Kim J, Chaurasia R Expert Rev Mol Med. 2024; 26:e32.

PMID: 39639643 PMC: 11629464. DOI: 10.1017/erm.2024.29.


Novel dual-pathogen multi-epitope mRNA vaccine development for Brucella melitensis and Mycobacterium tuberculosis in silico approach.

Zhu Y, Shi J, Wang Q, Zhu Y, Li M, Tian T PLoS One. 2024; 19(10):e0309560.

PMID: 39466745 PMC: 11515988. DOI: 10.1371/journal.pone.0309560.


References
1.
Zhang Y, Bliska J . Role of Toll-like receptor signaling in the apoptotic response of macrophages to Yersinia infection. Infect Immun. 2003; 71(3):1513-9. PMC: 148878. DOI: 10.1128/IAI.71.3.1513-1519.2003. View

2.
Monack D, Mueller A, Falkow S . Persistent bacterial infections: the interface of the pathogen and the host immune system. Nat Rev Microbiol. 2004; 2(9):747-65. DOI: 10.1038/nrmicro955. View

3.
Lewis B, Burge C, Bartel D . Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell. 2005; 120(1):15-20. DOI: 10.1016/j.cell.2004.12.035. View

4.
Rosenberg E . The diversity of bacterial pathogenicity mechanisms. Genome Biol. 2005; 6(5):320. PMC: 1175951. DOI: 10.1186/gb-2005-6-5-320. View

5.
Taganov K, Boldin M, Chang K, Baltimore D . NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci U S A. 2006; 103(33):12481-6. PMC: 1567904. DOI: 10.1073/pnas.0605298103. View